KFC, fwiw, if IPIX is successful with some B applications (sales) then I think the IPIX comment about further reviewing the data is relevant. With such a huge market and the potentially serious side effects of the immunologics there is room for a modestly effective, low side effect P. And given that a P derivate was once, actually still is, an HIV medicine shows it can have powerful effects in a cell. And besides, mice like it too.